Yang Yun, Dang Zheng, Lu Peng, Qian Youwen, Lin Kongying, Pan Zeya, Lau Wan Yee, Zhou Weiping
The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Department of Hepatobiliary Surgery, 940 Hospital of PLA Joint Logistic Support Force, Lanzhou, China.
Hepatobiliary Surg Nutr. 2022 Jun;11(3):386-399. doi: 10.21037/hbsn-20-700.
To study the influence of pathological responses (PR) after transcatheter arterial chemoembolization (TACE) on incidences of microvascular invasion (MVI) and early recurrence in hepatocellular carcinoma (HCC) patients.
Between 2013 to 2015, consecutive HCC patients who underwent liver resection with "curative" intent at three hospitals were enrolled in this study. Patients with different areas of PR after preoperative TACE were compared with those without preoperative TACE on the incidences of MVI, early recurrence rates and patterns of recurrence before and after propensity score matching (PSM).
Of 1,970 patients, 737 patients who received preoperative TACE were divided into three groups according to the areas of PR: ≥90% (n=226), 60-90% (n=447), and <60% (n=64). PR ≥90% was an independent protective factor of incidences of MVI [odds ratio (OR), 0.144; 95% confidence interval (CI), 0.082-0.245, P<0.001) and early recurrence (HR, 0.742; 95% CI, 0.561-0.963, P=0.032); while PR<60% was an independent risk factor of incidences of MVI (OR, 6.076; 95% CI, 3.004-11.728, P<0.001) and early recurrence (HR, 1.428; 95% CI, 1.095-1.929; P=0.009). Furthermore, patients with PR <60% were significantly more likely to develop multiple intrahepatic recurrences involving multiple hepatic segments when compared with patients without preoperative TACE.
This study indicated the area of PR after TACE was closely associated with the incidences of MVI and early tumor recurrence. Patients with PR <60% were at significantly higher risks of having more MVI, early and multiple tumor recurrences.
研究经动脉化疗栓塞术(TACE)后病理反应(PR)对肝细胞癌(HCC)患者微血管侵犯(MVI)发生率及早期复发的影响。
2013年至2015年期间,三家医院收治的有“根治性”意向并接受肝切除术的连续性HCC患者纳入本研究。术前TACE后PR面积不同的患者与未行术前TACE的患者在倾向评分匹配(PSM)前后的MVI发生率、早期复发率及复发模式方面进行比较。
1970例患者中,737例接受术前TACE的患者根据PR面积分为三组:≥90%(n = 226)、60 - 90%(n = 447)和<60%(n = 64)。PR≥90%是MVI发生率[比值比(OR),0.144;95%置信区间(CI),0.082 - 0.245,P<0.001]及早期复发(风险比,0.742;95% CI,0.561 - 0.963,P = 0.032)的独立保护因素;而PR<60%是MVI发生率(OR,6.076;95% CI,3.004 - 11.728,P<0.001)及早期复发(HR,1.428;95% CI,1.095 - 1.929;P = 0.009)的独立危险因素。此外,与未行术前TACE的患者相比,PR<60%的患者发生累及多个肝段的肝内多发复发的可能性显著更高。
本研究表明TACE后的PR面积与MVI发生率及肿瘤早期复发密切相关。PR<60%的患者发生更多MVI、早期及多发肿瘤复发的风险显著更高。